Analysis and Commentary STEVEN GROSSMAN 3/13/21 Analysis and Commentary STEVEN GROSSMAN 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More Analysis and Commentary STEVEN GROSSMAN 3/6/21 Analysis and Commentary STEVEN GROSSMAN 3/6/21 Critical Supply Chains and the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/21 Advocacy at a Glance STEVEN GROSSMAN 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More Analysis and Commentary STEVEN GROSSMAN 2/27/21 Analysis and Commentary STEVEN GROSSMAN 2/27/21 Questions (and Answers) About Current Political Issues Read More Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Analysis and Commentary STEVEN GROSSMAN 2/19/21 Analysis and Commentary STEVEN GROSSMAN 2/19/21 "FDA Exceptionalism," Redux (Again) Read More Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More Analysis and Commentary STEVEN GROSSMAN 2/13/21 Analysis and Commentary STEVEN GROSSMAN 2/13/21 FDA-related Provision of House Reconciliation Bill Read More Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More Analysis and Commentary STEVEN GROSSMAN 2/5/21 Analysis and Commentary STEVEN GROSSMAN 2/5/21 Alliance's "Ask" for FY 22: Member Input Is Requested Read More Advocacy at a Glance STEVEN GROSSMAN 2/5/21 Advocacy at a Glance STEVEN GROSSMAN 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More Analysis and Commentary STEVEN GROSSMAN 1/29/21 Analysis and Commentary STEVEN GROSSMAN 1/29/21 Biden's Budget Request for FY 22 and Related Issues Read More Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More Analysis and Commentary STEVEN GROSSMAN 1/21/21 Analysis and Commentary STEVEN GROSSMAN 1/21/21 Leadership and FDA Appropriation for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More Analysis and Commentary STEVEN GROSSMAN 1/16/21 Analysis and Commentary STEVEN GROSSMAN 1/16/21 Supporting a Budget Increase for FDA for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More Analysis and Commentary STEVEN GROSSMAN 1/8/21 Analysis and Commentary STEVEN GROSSMAN 1/8/21 Now We Know Who'll Be in Charge Read More Advocacy at a Glance STEVEN GROSSMAN 1/8/21 Advocacy at a Glance STEVEN GROSSMAN 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More STEVEN GROSSMAN 12/21/20 STEVEN GROSSMAN 12/21/20 FY 21 Appropriations Provisions and COVID-19 Relief / Stimulus Provisions Related to FDA Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 3/13/21 Analysis and Commentary STEVEN GROSSMAN 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More
Analysis and Commentary STEVEN GROSSMAN 3/6/21 Analysis and Commentary STEVEN GROSSMAN 3/6/21 Critical Supply Chains and the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/21 Advocacy at a Glance STEVEN GROSSMAN 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/21 Analysis and Commentary STEVEN GROSSMAN 2/27/21 Questions (and Answers) About Current Political Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Analysis and Commentary STEVEN GROSSMAN 2/19/21 Analysis and Commentary STEVEN GROSSMAN 2/19/21 "FDA Exceptionalism," Redux (Again) Read More
Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More
Analysis and Commentary STEVEN GROSSMAN 2/13/21 Analysis and Commentary STEVEN GROSSMAN 2/13/21 FDA-related Provision of House Reconciliation Bill Read More
Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More
Analysis and Commentary STEVEN GROSSMAN 2/5/21 Analysis and Commentary STEVEN GROSSMAN 2/5/21 Alliance's "Ask" for FY 22: Member Input Is Requested Read More
Advocacy at a Glance STEVEN GROSSMAN 2/5/21 Advocacy at a Glance STEVEN GROSSMAN 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More
Analysis and Commentary STEVEN GROSSMAN 1/29/21 Analysis and Commentary STEVEN GROSSMAN 1/29/21 Biden's Budget Request for FY 22 and Related Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More
Analysis and Commentary STEVEN GROSSMAN 1/21/21 Analysis and Commentary STEVEN GROSSMAN 1/21/21 Leadership and FDA Appropriation for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More
Analysis and Commentary STEVEN GROSSMAN 1/16/21 Analysis and Commentary STEVEN GROSSMAN 1/16/21 Supporting a Budget Increase for FDA for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More
Analysis and Commentary STEVEN GROSSMAN 1/8/21 Analysis and Commentary STEVEN GROSSMAN 1/8/21 Now We Know Who'll Be in Charge Read More
Advocacy at a Glance STEVEN GROSSMAN 1/8/21 Advocacy at a Glance STEVEN GROSSMAN 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More
STEVEN GROSSMAN 12/21/20 STEVEN GROSSMAN 12/21/20 FY 21 Appropriations Provisions and COVID-19 Relief / Stimulus Provisions Related to FDA Read More
